IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Management of Stage III Non-Small Lung Cancer
December 04, 2017 | Online


This program will examine current treatment standards for stage III non-small cell lung cancer (NSCLC). Advances in radiation therapy and novel systemic treatments will be highlighted. Recent data presented at ESMO 2017, ASTRO 2017 and WCLC 2017 that is most likely to impact patient care will be discussed. The status of immunotherapy for stage III disease will also be addressed.

In this session, the faculty will:

  • Identify advances in radiation therapy for lung cancer that were shared at ESMO 2017, ASTRO 2017 and WCLC 2017;
  • Outline how new, innovative approaches may be incorporated into clinical practice, and
  • Discuss the clinical research developments that are likely to impact patient care and future clinical studies. 


Pr Françoise Mornex, MD, PhD
Département de Radiothérapie
Centre Hospitalier Lyon Sud
Lyon, France


Maria Werner-Wasik, MD, FASTRO

Director of Clinical Research
Department of Radiation Oncology
Thomas Jefferson University
Philadelphia, Pennsylvania


Benjamin Besse, MD, PhD

Department of Medical Oncology,
Institut Gustave Roussy
Paris, France